effects of Bromocriptine and Metformin on polycystic ovary syndrome
Phase 2
- Conditions
- Polycystic ovary syndrome.Polycystic ovarian syndrome
- Registration Number
- IRCT201512313461N7
- Lead Sponsor
- ?Vice chancellor for research, Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 64
Inclusion Criteria
Inclusion criteria : menstrual cycles greater than 40 days; acnea; hirsutism; pco on sonography; LH/FSH ratio greater than 2; normal prolactin; normal TSH; excess androstenedione; normal blood sugar. Exclusion criteria: marriage; psychiatric drug users; professional athletes; primary amenorrhea; history of chronic illnesses; body mass index greater than 30 kg/m2.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Menstrual pattern. Timepoint: Before , 3 and 6 months after intervention. Method of measurement: Questionnaire, menstrual cycle days measurement.
- Secondary Outcome Measures
Name Time Method